Document:

EX-10.78

 Exhibit 10.78 

 
  

QUINTILES IMS HOLDINGS, INC. 

Non-Employee Director Deferral Plan 

Effective January 1, 2017 
  

 
  

	 	1.	Purpose of the Plan; Status as Sub-Plan. 

 The
purpose of this Non-Employee Director Deferral Plan (the “Plan”) is to provide a convenient means for non-employee directors to increase their proprietary
interest in Quintiles IMS Holdings, Inc., a Delaware corporation (the “Company”), in order to further align their interests with the interests of stockholders of the Company and to help the Company attract and retain qualified directors.
The Plan allows non-employee directors to defer the receipt of cash compensation, with the ultimate payout of such deferred compensation to be in the form of Shares of Company common stock. 

The Plan shall be deemed to be a subplan implementing the Company’s 2013 Stock Incentive Plan (the “2013 Plan”) or any other
legally permissible successor plan. All references herein to 2013 Plan, shall also include references to the applicable sections of any legally permissible successor plans. Accordingly, Deferred Shares shall be deemed to be Awards governed by the
2013 Plan, and any Shares delivered in connection with such Awards shall be drawn from the 2013 Plan. The provisions of the 2013 Plan, are incorporated herein by reference. The effective date of the Plan is January 1, 2017 (the “Effective
Date”). 
  

	 	2.	Definitions. 

 Capitalized terms used herein have the definitions specified in the 2013
Plan, (including “Award,” “Board,” “Exchange Act,” “Fair Market Value” and “Share”). In addition, certain capitalized terms are defined in Section 1 above and in other Sections below, and the
terms set forth in this Section 2 have definitions as follows: 
 (a) Administrator: The Company’s Chief Human Resources Officer,
and/or any other officer or committee of employees designated by the Committee to serve individually or by committee as Administrator. 

(b) Change in Control: The occurrence of any of the following events after the Effective Date: 

 

	 	(i)	 Any “person,” as such term is used in Section 13(d) and 14(d) of the Exchange Act (other than the
Company, any trustee or other 

	 	
fiduciary holding securities under an employee benefit plan of the Company, or any company owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions
as their ownership of stock of the Company), acquires voting securities of the Company and immediately thereafter is the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly
or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company’s then-outstanding voting securities; 

  

	 	(ii)	Individuals who on January 1 of any year constitute the Board of Directors, and any new director (other than a director whose initial assumption of office is in connection with an actual or threatened election
contest, including but not limited to a consent solicitation, relating to the election of directors of the Company) whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors on that January 1 or whose election or nomination for election was previously so approved or recommended, cease for any reason to
constitute at least a majority thereof; 

  

	 	(iii)	There is consummated a merger, consolidation, recapitalization, or reorganization of the Company, or a reverse stock split of any class of voting securities of the Company, if, immediately following consummation of any
of the foregoing, either (A) individuals who, immediately prior to such consummation, constitute the Board do not constitute at least a majority of the members of the board of directors of the Company or the surviving or parent entity, as the
case may be, or (B) the voting securities of the Company outstanding immediately prior to such event do not represent (either by remaining outstanding or by being converted into voting securities of a surviving or parent entity) at least 50% or
more of the combined voting power of the outstanding voting securities of the Company or such surviving or parent entity; or 

  

	 	(iv)	The stockholders of the Company have approved a plan of complete liquidation of the Company and there occurs a distribution pursuant to such plan of complete liquidation, and all material contingencies to the completion
of the transaction have been satisfied or waived, or there is consummated an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets (or any transaction have a similar effect). 

(c) Committee: The Leadership Development and Compensation Committee of the Board. 

  
 2 

 (d) Deferred Share: A bookkeeping entry, equivalent in value to one Share, credited to a
Participant’s Plan Account under the Plan. A Deferred Share represents an Other Stock-Based Award under Section 10.2 of the 2013 Plan, (the terms of which are similar to a fully vested Restricted Stock Unit under 2013 Plan Article 8). 

(e) Determination Date: As such term is defined in Section 6(b) of the Plan. 

(f) Participant: Any director of the Company who is eligible to participate under Section 4 and has validly elected to participate in the
Plan, from the earliest service period that is subject to his or her initial deferral election and for so long as such person continues to have Deferred Shares or other amounts credited to his or her Plan Account. 

(g) Plan Account: A bookkeeping account to which cash amounts and Deferred Shares may be credited as deferred compensation. 

(h) Plan Rights: Fees and other compensation subject to a valid election to defer under the Plan, any Plan Account and Deferred Shares and
cash credited thereto, any rights to future distribution and any related rights of a Participant or a Beneficiary. 
  

	 	3.	Administration 

 The Plan will be administered by the Committee. The Committee is
authorized to interpret the Plan, to establish, amend and rescind any rules and regulations relating to the Plan, and to make any other determinations that it deems necessary or desirable for the administration of the Plan. The Committee may correct
any defect or supply any omission or reconcile any inconsistency in the Plan in the manner and to the extent the Committee deems necessary or desirable. Any decision of the Committee in the interpretation and administration of the Plan, as described
herein, shall lie within its sole and absolute discretion and shall be final, conclusive and binding on all parties concerned (including, but not limited to, Participants and their beneficiaries or successors). The foregoing notwithstanding, the
Board may exercise any power or perform any function of the Committee, in which case any applicable reference to “Committee” herein shall be deemed to refer to the Board. No Participant shall participate in any determination relating
solely or primarily to his or her Plan Rights. The foregoing notwithstanding, the Administrator will perform the functions assigned to it in the Plan together with all other ministerial functions under the Plan. 

  
 3 

	 	4.	Eligibility 

 A person serving as a director who, at the date an election to defer
compensation may be validly filed, is not an employee of the Company or its subsidiaries, is eligible to become a Participant under this Plan. 
  

	 	5.	Voluntary Deferral of Cash Compensation 

 A person eligible under Section 4 may
voluntarily elect to defer his or her cash compensation for services as a Company director, in accordance with the Plan. 
 (a)
Compensation that May be Deferred. Compensation that may be deferred includes annual retainer fees for service on the Board or Board committees, including service as a Board or committee chair or in any leadership
capacity, meeting fees for service on the Board or committees (if any), and any other cash fees paid for service as a director. The following items may not be deferred hereunder: 

 

	 	•	 	An equity award to a director that is accounted for under Financial Accounting Standards Board Accounting Standards Codification Topic 718 (“FASB ASC 718”), even if such award is settled in cash;

  

	 	•	 	Any reimbursement for expenses; and 

  

	 	•	 	Any compensation paid for services as an employee or consultant. 

 (b) Method Of
Election. To elect to participate in the Plan, the Participant must complete and deliver to the Administrator a written election, not later than the latest of (1) 30 days after the date on which he or she commences service as a director of
the Company, (2) 30 days after the Effective Date or (3), for deferrals to occur in the year following the filing of the election to defer, not later than December 31 of the year preceding that following year; provided that the Administrator
may specify any other deadline (earlier or later than specified in (1) – (3) above) so long as such deadline ensures effective tax deferral by the Participant and conforms to all applicable requirements of Code Section 409A. The written
election: 
  

	 	(i)	Shall be on a form specified by the Administrator. 

  

	 	(ii)	Shall permit Participant to designate all or a portion of the Participant’s cash compensation for the applicable year of service as a director as the amount to be deferred. The Administrator may determine whether
this designation shall be as a dollar amount, a percentage or any other manner of designation. 

  

	 	(iii)	Shall permit the Participant to elect the time of distribution of Deferred Shares (subject to Section 6), which may be specific to the Deferred Shares resulting from deferral in a specified year (i.e., a different
distribution election may apply to deferrals in different years). 

  
 4 

	 	(iv)	With respect to elections under both (ii) and (iii) above, shall remain effective for all future years of service unless the Participant makes a new valid election in a subsequent year by the applicable deadline
for such elections or unless the Administrator has determined, and advised the Participant before such deadline, that the prior election will not remain in effect. 

 

	 	(v)	Shall apply only to director compensation that is payable for services performed after the filing of such election. Accordingly, if a new director were to elect to participate within the
30-day period after becoming a director, any fees paid after the date of the election allocable (as provided under Code Section 409A) to services performed during the
30-day period and before the date of the election would not be deferrable. This restriction may also apply to directors electing to participate within 30 days after the Effective Date. 

 

	 	(vi)	Shall be irrevocable to the extent provided under Code Section 409A; modifications to distribution elections are not permitted. 

(c) Crediting of Deferred Shares; Dividend Equivalents and Adjustments. Deferred
Shares and related amounts will be credited to a Participant’s Plan Account as follows: 
  

	 	(i)	The number of Deferred Shares to be credited on a given day will be determined by dividing (i) the amount of cash compensation to be deferred (and other cash then credited to the Plan Account) by (ii) 100% of the
Fair Market Value of one Share on that day. 

  

	 	(ii)	The Administrator may determine to credit fractional shares (subject to reasonable rounding), or not to credit fractional shares but instead to carry forward in the Plan Account as a cash credit any amount that would
have resulted in the crediting of a fractional share. 

  

	 	(iii)	The crediting of Deferred Shares to a Participant’s Account will occur on one or more days in each calendar quarter. Unless otherwise determined by the Administrator, such crediting will occur on the regular date
on which cash retainer fees are paid to non-employee directors (or would be paid but for the director’s deferral election). If, on a date other than such regular quarterly payment date, any fees subject
to deferral are payable to a director or any cash amounts are credited to the Participant’s Plan Account under Section 5(c)(iv) or (v) (dividend equivalents or adjustments), then, unless otherwise determined by the Administrator, those credited
amounts will remain as cash credits until the next scheduled date for the crediting of Deferred Shares. 

  
 5 

	 	(iv)	Dividend equivalents will be credited on each Deferred Share, in a cash amount equal to the regular dividends (if any) or non-regular cash dividends (if any) paid on one Share.
Such crediting will take place as of the payment date of the corresponding dividend. 

  

	 	(v)	Deferred Shares will be adjusted as provided under Section 4.4 of the 2013 Plan, provided that the Participant will have a legal right to an adjustment in the event of an equity restructuring as that term is used
in FASB ASC 718, and provided further that any adjustment will take into account the extent of any crediting of dividend equivalents under Section 5(c)(iv) in connection with the events triggering the adjustment. An adjustment may be effected
through the crediting of additional cash to the Participant’s Plan Account, if so determined by the Committee. 

  

	 	6.	Distributions. 

 (a) Generally. All distributions from a Participant’s Plan
Account will be made after termination of the Participant’s service as a director of the Company as provided in Section 6(b), upon a Change in Control as provided in Section 6(c) or in the event of Participant’s death as provided in
Section 6(d). A distribution of Deferred Shares shall be in the form of whole Shares equal to the number of Deferred Shares being distributed, provided that any distribution on a final distribution date will include payment of the value of any
fractional Share in cash based on the Fair Market Value of a Share as of that distribution date together with payment of any cash balance in the Participant’s Plan Account. 

(b) Distributions Elected by the Participant. With regard to Deferred Shares or other Account balances
resulting from deferrals in a given calendar year, a Participant may elect distributions as follows, subject to Section 6(d) (applicable in the event of Participant’s death): 

 

	 	•	 	As a lump sum on the first business day of the calendar year immediately following the date on which the Participant has a separation from service with the Company (the “Determination Date”);

  

	 	•	 	As a lump sum on the fifth anniversary of the Determination Date; or 

  

	 	•	 	 As annual installments payable commencing on the Determination Date or the fifth anniversary of the Determination
Date (and in subsequent years on the first day of the month in which the Determination Date fell), such number of installments (not to exceed ten if commencing on the Distribution Date or five if commencing on the fifth anniversary of the
Determination date), to be elected by the Participant in accordance with Section 5(b). The Shares distributable in a given installment will be 

  
 6 

	 	 
determined by dividing the number of Deferred Shares then credited to the Participant’s account by the number of remaining scheduled installments (including the given installment), with the
resulting number of Deferred Shares rounded down to the nearest whole Share, with no payment in lieu of a fractional share until the final installment is distributed. Any cash distributable in a given installment will be determined in a similar
manner, reduced to the nearest whole cent. 

 The Participant shall elect the distribution date for deferrals at the same time as he or
she elects to participate in the Plan under Section 5(b), provided that, if no valid election relating to distribution is on file, the Participant shall be deemed to have elected a lump sum distribution to be made on the Determination Date. 

(c) Change In Control. In the event of a Change in Control that constitutes (or involves related transactions that
constitute) a change in the ownership of the Company, a change in the effective control of the Company, or a change in the ownership of a substantial portion of the Company’s assets within the meaning of Treasury Regulation § 1.409A-3(i)(5)(v) – (vii) and any successor thereto (a “409A Change in Control”), Deferred Shares will be distributed in a lump sum not later than five business days after the 409A Change in Control,
provided that such distribution shall be simultaneous with the 409A Change in Control if necessary to permit Participants to participate in a transaction that is related to the 409A Change in Control, such as a merger or tender offer. 

(d) Death of the Participant. In the event of the Participant’s death, all remaining Deferred Shares and any
other amounts credited to the Participant’s Plan Account will be distributed not later than the end of the calendar year following the year of death in accordance with applicable regulations (including proposed regulations) under Code Section
409A. 
 (e) Effect of Participant Becoming an Employee or Consultant. If a
Participant ceases to serve as a director but becomes or has become an employee of or consultant to the Company or any of its subsidiaries, whether such Participant will be deemed to have a separation from service for purposes of Section 6(b) will
be determined in accordance with Treasury Regulation § 1.409A-1(h). 
  

	 	7.	Nontransferability of Plan Rights; Forfeiture. 

 Plan Rights, including Deferred Shares
and any other amounts credited to the Participant’s Plan Account, are subject to the restrictions on transferability applicable to an Award as set forth in Section 11.1 of the 2013 Plan, including provisions permitting the designation of a
Beneficiary. No provision of the Plan imposes any risk of forfeiture on a Participant’s Plan Rights, except that those rights will remain forfeitable to the extent the compensation deferred that resulted in the Deferred Shares or cash credited
to the Plan Account would have been forfeitable or subject to recoupment absent deferral. 

  
 7 

	 	8.	Other Provisions 

 (a) Unfunded Plan. The Plan is subject to
Section 20.11 of the 2013 Plan. Accordingly, the interest of each Participant in Plan Rights shall be that of a general creditor of the Company, and Plan Rights shall at all times be maintained by the Company as bookkeeping entries evidencing
unfunded and unsecured general obligations of the Company. The Plan shall be unfunded, and therefore no money or other assets of the Company shall be set aside for any Participant. 

(b) Other Applicable 2013 Plan Provisions. For reference, applicable provisions of the 2013 Plan include
(but are not limited to) the provisions relating to legal compliance (2013 Plan Sections 20.4, 20.5 and 20.6), governing law (2013 Plan Section 20.17), limitation on rights as a stockholder or rights to continue in service (2013 Plan Article
16), and severability (2013 Plan Section 20.3). 
 (c) Successors and Assigns. The Plan shall be binding on all
successors and assigns of the Company and each Participant, including a Participant’s Beneficiaries, estate and any executor, administrator or trustee of such estate, or any receiver or trustee in bankruptcy or representative of the
Participant’s creditors. 
 (d) Amendment and Termination. The Board or the Committee may amend, modify, suspend
or terminate the Plan, but no such action may be taken if it would materially and adversely affect the rights of a Participant under the Plan without such Participant’s consent. Unless earlier terminated by action of the Board, the Plan will
remain in effect until such time as no Shares remain available for delivery under the Plan and the Company has no further rights or obligations under the Plan. 

(e) Section 409A of the Code; Tax Obligations. Other provisions of this Plan notwithstanding,
if any distribution under the Plan could cause a Participant to incur an accelerated or additional tax or penalty under Code Section 409A, such payment or other benefits will be deferred if deferral will make such payment or other benefits compliant
under Section 409A of the Code (for instance, if the Participant is a “specified employee” within the meaning of Section 409A of the Code and would receive a distribution hereunder within six months after a separation from
service, such distribution shall be delayed until the earlier of the Participant’s death or six months and one day following the Participant’s separation from service), or otherwise such payment or other benefits will be restructured (but
not reduced), to the extent possible, in a manner reasonably determined by the Administrator to not cause such an accelerated or 

  
 8 

 
additional tax or penalty. The Plan, in its terms and operation, is intended to comply with Code Section 409A and will be interpreted accordingly, and will be automatically modified to the extent
necessary to so comply. References herein to a Participant’s termination of employment or separation from service shall be deemed to refer to the date upon which the Participant has a “separation from service” within the meaning of
Code Section 409A. Each distribution hereunder, including each installment if installments are elected, constitutes a “separate payment” for purposes of Code Section 409A. The Participant remains responsible for all taxes payable by the
Participant in respect of the compensation deferred under the Plan, Plan Rights and distributions hereunder, including any accelerated or additional tax or penalty under Code Section 409A, and the Company will not indemnify, “gross-up” or otherwise reimburse the Participant for any tax obligation resulting to the Participant from participation in the Plan or otherwise relating to Participant’s compensation as a director
of the Company. 

  
 9EX-10.104

 Exhibit 10.104 
  

 
 November 30, 2016 
 W.
Richard Staub III 
 3210 Merriman Avenue 
 Raleigh, NC 27607

 Dear Richard, 
 We are very pleased to extend this offer
for the role of President, Research & Development Solutions, of Quintiles IMS Incorporated (the “Company”), a subsidiary of Quintiles IMS Holdings, Inc. (“QuintilesIMS”). Subject to satisfaction of all the
conditions described in this letter, your employment in this new role will commence on December 1, 2016 (the “Start Date”). 

In consideration for your services and the execution of the Non-Competition,
Non-Solicitation, Confidentiality and Intellectual Property Agreement set forth in Schedule A attached hereto (the “Restrictive Covenant Agreement”), you will be paid a
base salary of $540,000 per year, subject to annual review. The base salary shall be payable in periodic installments in accordance with the standard payroll practices of the Company and subject to all withholdings and deductions as required by law.
Your principal place of employment shall be at the Company’s offices in Raleigh-Durham, North Carolina, subject to business travel as needed to properly fulfill your employment duties and responsibilities. 

During your employment, you will be eligible to participate in the Company’s Annual Incentive Plan (or such successor or additional plans, the
“AIP”) on the same terms and conditions as other similarly situated executives. Your annual target bonus opportunity will be 85% of base salary. You will continue to be eligible to participate in the employee benefit plans and
programs generally available to the Company’s senior executives, subject to the terms and conditions of such plans and programs. The Company reserves the right to amend, modify or terminate any of its benefit plans or programs at any time and
for any reason. 
 You will also be eligible to receive an annual equity award commensurate with amounts, terms and conditions applicable to similarly
situated executive officers of the Company, subject to the applicable terms, conditions and eligibility requirements of the equity plans and programs of QuintilesIMS, as they may exist from time to time, and the approval of the Leadership
Development and Compensation Committee of the Board of Directors of QuintilesIMS in its discretion. 
 Effective on the Start Date, your employment will be
subject to the terms and conditions set forth in this letter, and any employment agreement between you and QuintilesIMS or any affiliate thereof, including the agreement executed as of August 13, 2013 between you and Novella Clinical, Inc.
(“Employment Agreement”), shall terminate and have no further force or effect except as expressly described in this offer letter. 

This offer of employment is contingent upon: (1) your agreement to the terms and conditions set forth in this offer letter and (2) your agreement to
the terms and conditions set forth in the Restrictive Covenant Agreement. 
 You acknowledge and agree you are receiving good, valuable and adequate
consideration for your agreement to the terms of this offer letter, including the promotion and increased responsibility reflected in your new role in the Company as described above. 

  
 1 of 4 

 This offer letter shall not be construed as constituting a contract for employment, or otherwise set forth a
length of employment. Rather, your employment will be at-will, meaning that you or the Company may terminate the employment relationship at any time, with or without cause, and for any reason or no particular
reason in accordance with the terms of this letter.
 If your employment with the Company is terminated by the Company other than for Cause, subject to your
execution and non-revocation of a release of claims in a form provided by the Company and your compliance with the Restrictive Covenant Agreement, you will be eligible to receive severance in an aggregate
amount equal to the sum of (1) an amount equal to twenty-four (24) months of base salary in effect at the time of your termination, (2) an amount equal to your annual target bonus opportunity in effect for the year of termination, and
(3) an amount equal to the projected cost of the continuation of your group health insurance coverage for you and your eligible dependents pursuant to COBRA for the eighteen (18) months following the termination date (together, the
“Severance Payment”). The Severance Payment shall be payable in equal monthly installments on the Company’s regular payroll schedule during the twenty-four month non-competition
period pursuant to the Restrictive Covenant Agreement, with the first installment to be paid on the first regular payroll date occurring after the 30th day following your termination date;
provided that if the review and revocation period for the release begins in one taxable year and ends in another taxable year, payments shall not begin until the beginning of the second taxable year; and provided further that the first
installment will include all amounts that would otherwise have been paid to you since the period beginning on the termination date if no delay had been imposed. The severance payable pursuant to this paragraph shall be in lieu of any benefits under
any other severance plan of the Company. 
 For purposes of this offer letter, “Cause” means the occurrence of any of the following:
(i) any willful misconduct or omission or act of dishonesty by you, which as determined by the Company in its reasonable discretion, may cause material harm to the Company or its affiliates, or any other actions that are materially detrimental
to the Company or any affiliates’ interest; (ii) gross negligence or willful misconduct by you in the performance of your duties; (iii) any material act by you of fraud or intentional misrepresentation or embezzlement,
misappropriation or conversion of assets, whether or not related to your employment with the Company; (iv) you being indicted for, convicted of, confessing to, pleading nolo contendere or becoming the subject of proceedings that provide a
reasonable basis for the Company to believe that you have engaged in, a felony or in any other crime involving dishonesty or moral turpitude; (v) your material violation of a provision of the Company’s code of conduct, ethics policy or
other material policy of the Company, which as determined by the Company in its reasonable discretion may be materially detrimental to the Company or any affiliates’ interest; (vi) your material breach of fiduciary duty to the Company or
its affiliates which as determined by the Company in its reasonable discretion may be materially detrimental to the Company or any affiliates’ interest; or (vii) your material breach of this offer letter, the Restrictive Covenant Agreement
or any other written agreement between you and the Company which as determined by the Company in its reasonable discretion may be materially detrimental to the Company or any affiliates’ interest; provided that, “Cause” shall
not be deemed to have occurred pursuant to subsections (v) and (vii) hereof unless you have first received written notice from the Company specifying in reasonable detail the particulars of such grounds and that Company intends to terminate
your employment hereunder for such reason, and if such ground is reasonably capable of being cured within fifteen (15) days, you have failed to cure such ground within a period of fifteen (15) days from the date of such notice. The Company
may place you on paid leave while it is determining whether there is a basis to terminate your employment for Cause or during the above-referenced cure period. 

This offer letter shall be governed by the laws of North Carolina, without regard to conflict of law principles. This offer letter may be signed in any number
of counterparts (including via facsimile and electronic transmission), each of which will be deemed to be an original and all of which together will constitute one and the same instrument. No provision of this offer letter may be amended or modified
unless agreed to in writing and signed by you and the Company. 
 Section 409A 

This offer letter is intended to comply with Section 409A of the Internal Revenue Code (“Section 409A”) or an exemption thereunder and
shall be construed and administered in accordance with Section 409A. Notwithstanding any other provision of this offer letter, payments provided under this offer letter may only be made upon an event and in a manner that complies with Section 409A
or an applicable exemption. Any payments under this offer letter 

  
 2 of 4 

 
that may be excluded from Section 409A either as separation pay due to an involuntary separation from service or as a short-term deferral shall be excluded from Section 409A to the maximum extent
possible. For purposes of Section 409A, each installment payment provided under this offer letter shall be treated as a separate payment. Any payments to be made under this offer letter upon a termination of employment shall only be made upon a
“separation from service” under Section 409A. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this offer letter comply with Section 409A and in no event shall the Company be
liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by you on account of non-compliance with Section 409A. 

Notwithstanding any other provision of this offer letter, if any payment or benefit provided to you in connection with termination of employment is determined
to constitute “nonqualified deferred compensation” within the meaning of Section 409A and you are determined to be a “specified employee” as defined in Section 409A(a)(2)(b)(i), then such payment or benefit shall not be paid
until the first payroll date to occur following the six-month anniversary of your termination date (the “Specified Employee Payment Date”) or, if earlier, on the date of
your death. The aggregate of any payments that would otherwise have been paid before the Specified Employee Payment Date shall be paid to you in a lump sum on the Specified Employee Payment Date and thereafter, any remaining payments shall be paid
without delay in accordance with their original schedule. 

  
 3 of 4 

 We eagerly await your acceptance in writing and look forward to working with you in this role, where we are
confident you will find enormous opportunity for growth and development. 
  

	
	Yours sincerely,
	
	 /s/ Ari Bousbib

	Ari Bousbib
	On behalf of Quintiles IMS Incorporated

 I have read, understood and accept all the terms of the offer of employment as set forth in the foregoing letter. I have not
relied on any agreements or representations, express or implied, that are not set forth expressly in this letter, and this letter supersedes all prior and contemporaneous understandings, agreements, representations and warranties, both written and
oral, with respect to the subject matter of this letter, except as expressly set forth herein. 
  

					
	 /s/ W. Richard Staub III
	 		 	 November 30, 2016

	W. Richard Staub III	 		 	Date

  
 4 of 4 

 Schedule A 

  
 5 

 

 
 NON-COMPETITION,
NON-SOLICITATION, CONFIDENTIALITY AND 
 INTELLECTUAL PROPERTY AGREEMENT 

This Non-Competition, Non-Solicitation, Confidentiality and
Intellectual Property Agreement (the “Agreement”) is made by and between W. Richard Staub III (the “Executive”) and Quintiles IMS Incorporated (the “Company”), a subsidiary of Quintiles IMS
Holdings, Inc. (“QuintilesIMS”). This Agreement will become effective immediately upon the date Executive executes the letter agreement dated November 30, 2016 to which this Agreement is Exhibit A (the “Letter
Agreement”). 
 WHEREAS, Executive has been employed by the Company and his employment is being continued in a senior executive
position with the Company as of the Start Date set forth in the Letter Agreement. As an employee, he will have responsibilities that embrace all of the services provided by the Company and will have access to confidential information and trade
secrets of the Company and its Affiliates, including but not limited to valuable information about their worldwide business operations and the persons and entities with which they do business in various locations throughout the world and he will
develop relationships with their customers and others with which they do business in various locations throughout the world; and 
 WHEREAS,
Executive is already obligated under existing agreements with Affiliates of the Company to comply with restrictive covenants similar to those contained in this Agreement, but Executive agrees that because of the information and relationships to
which Executive will be exposed in anticipation of and during the course of Executive’s performance of his new role with the Company, it would be harmful to the Company, QuintilesIMS and its Affiliates for Executive to compete with Company,
QuintilesIMS or its Affiliates or solicit their clients, customers or employees in the manner prohibited by this Agreement and that the Company, QuintilesIMS and its Affiliates have legitimate business interests in protecting themselves from such
competition and solicitation. 
 NOW, THEREFORE, in consideration of the mutual covenants, promises and obligations set forth herein and in
the accompanying Letter Agreement, the parties agree as follows: 
 1. Nondisclosure. 

1.1. Recognition of Company’s Rights; Nondisclosure. Executive understands and acknowledges that during the course of his
employment by the Company, Executive will have access to and learn about Confidential Information, as defined below, relating to the Company and its Affiliates, and the Company Business. Executive further understands and acknowledges that this
Confidential Information, and the Company’s ability to reserve it for the exclusive knowledge and use of the Company and its Affiliates, is of great competitive importance and commercial value to the Company, and that improper use or disclosure
of the Confidential Information by Executive will cause irreparable harm to the Company and its Affiliates, for which remedies at law will not be adequate. At all times during Executive’s employment, and thereafter, Executive will hold in
strictest confidence and will not disclose or use any Confidential Information, except as such disclosure or use may be required in connection with Executive’s work for the Company, or unless and to the extent the Company expressly authorizes
such in writing. Executive will obtain the Company’s written approval before publishing or submitting for publication any material (written, verbal, or otherwise, including without limitation presentations, abstracts or posters) that relates to
Executive’s work at the Company, relates to the Company’s Business, and/or incorporates any Confidential Information. 
 1.2.
Assignment. Executive agrees to assign and hereby assigns to the Company any rights Executive may have or acquire in any knowledge, data or information that is made, authored, conceived, developed, or reduced to practice by Executive during
the period of Executive’s employment with the Company and which (but for Executive’s rights therein) would constitute Confidential Information, and Executive recognizes that all Confidential Information shall be the sole property of the
Company. 

  
 6 

 1.3. Subpoena or Court Order. If Executive is required to disclose Confidential
Information pursuant to a court order, subpoena or other government process or such disclosure is necessary to comply with applicable law or defend against claims, Executive shall: (i) notify the Company promptly before any such disclosure is
made; (ii) at the Company’s request and expense take all reasonably necessary steps to defend against such disclosure, including defending against the enforcement of the court order, other government process or claims; and
(iii) permit the Company to participate with counsel of its choice in any proceeding relating to any such court order, subpoena, other government process or claims. 

1.4. Duration of Confidentiality Obligations. Executive understands and acknowledges that Executive’s obligations under this
Agreement with regard to any particular Confidential Information or Trade Secret shall commence immediately upon Executive first having access to such Confidential Information or Trade Secret and shall continue during and after Executive’s
employment by the Company until such time as such Confidential Information or Trade Secret has become public knowledge other than as a result of Executive’s breach of this Agreement or breach by those acting in concert with Executive or on
Executive’s behalf and shall not continue longer than ten (10) years after Executive’s separation from service as an employee. 

1.5. Confidential Information. The term “Confidential Information” includes, but is not limited to:
(i) all information not generally known to the public, in spoken, printed, electronic or any other form or medium, relating directly or indirectly to the Company Business, is of value and is treated as confidential, including, but not limited
to, future business plans, financial information, business plans, strategic plans, pricing information, licensing strategies, advertising campaigns, information regarding executives and employees, and the terms and conditions of this Agreement; and
(ii) information of the Company, or its Affiliates and its and/or their licensors, suppliers, customers, or prospective licensors or customers, including, but not limited to, data, formulas, patterns, compilations, programs, devices, methods,
techniques, processes, financial data, financial plans, product plans, or lists of actual or potential customers or suppliers, which: (aa) derives independent actual or potential commercial value, from not being generally known to or readily
ascertainable through independent development or reverse engineering by persons or entities who can obtain economic value from its disclosure or use; and (bb) is the subject of efforts that are reasonable under the circumstances to maintain its
secrecy (“Trade Secret”). Notwithstanding anything otherwise in this Agreement to the contrary, Confidential Information shall not include information that is generally known or available to the public unless such information
became so known or available as a consequence of a breach by Executive of Executive’s obligations pursuant to this Agreement. 
 1.6.
Third Party Information. Executive understands, in addition, that the Company has received and in the future will receive from third parties confidential or proprietary information (“Third Party Information”)
subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain limited purposes. During the term of Executive’s employment and thereafter, Executive will hold Third Party
Information in the strictest confidence and will not disclose to anyone or use the Third Party Information, except as and to the extent permitted under this Agreement with respect to Confidential Information in connection with Executive’s work
for the Company. 
 1.7. No Improper Use of Information of Prior Employers and Others. During Executive’s employment with the
Company, Executive will not improperly use or disclose any Confidential Information of any former employer or any other person to whom Executive has an obligation of confidentiality. Executive will not bring onto the premises of the Company any
unpublished documents or any property belonging to any former employer or any other person to whom Executive has an obligation of confidentiality unless consented to in writing by that former employer or person. Executive will use in the performance
of Executive’s duties only information which is generally known and used by persons with training and experience comparable to Executive’s own, which is common knowledge in the industry or otherwise legally in the public domain, or which
is otherwise provided or developed by the Company or Executive. Executive represents that Executive’s performance of all the terms of this Agreement and as an employee of the Company will be consistent with the obligations set forth in
Section 1 of this Agreement. 

  
 7 

 1.8. Acknowledgement upon Termination of Employment. Executive agrees that upon
termination of Executive’s employment, without limiting Executive’s obligations hereunder, and if requested by the Company, Executive will acknowledge Executive’s possession of Confidential Information by signing an appropriate list
of all Confidential Information of which Executive has knowledge or about which Executive has acquired information. 
 2. Competitive Business
Activities. Executive acknowledges that by virtue of Executive’s employment by and senior position with the Company, (i) Executive will have responsibilities that embrace each of the services provided within the Company Business (as
defined in Section 2.7); (ii) the Company operates the Company Business through employees of Company as well as a network of entities subsidiary to or affiliated with the Company, or owned by subsidiaries or Affiliates of the Company
located throughout the world; (iii) by virtue of Executive’s employment by and senior position with the Company, Executive will have access to Confidential Information (as defined in this Agreement) of the Company and its Affiliates,
including but not limited to valuable information about their worldwide business operations and the persons and entities with which they do business in various locations throughout the world and will develop relationships with their customers and
others with which they do business in various locations throughout the world; and (iv) the restrictions set forth in this Section 2 are reasonably necessary to protect the Company’s legitimate business interests, are reasonable as to
time, territory, and scope of prohibited activities, do not interfere with the public policy or public interest, and are described with sufficient accuracy and definiteness to enable Executive to understand the scope of the restrictions imposed.

 2.1. Covenant Not to Compete. During Executive’s employment and the twenty-four (24) month period following the end of
Executive’s employment, Executive shall not, within the geographic territory identified in Section 2.4, do any of the following, whether or his own behalf or as an officer, director, stockholder, partner, associate, owner, employee,
consultant or independent contractor, nor shall Executive provide material assistance to any other person or entity to do so: 
  

	 	(a)	engage in the Company Business in competition with the Company or any Restricted Affiliate; 

  

	 	(b)	engage in the Company Business in any role that is the same as or materially similar to the role that he performed for the Company, in competition with the Company or any Restricted Affiliate; or 

 

	 	(c)	engage in the Company Business in competition with the Company or any Restricted Affiliate, in any role the performance of which would be reasonably presumed to require or involve the use or disclosure of Confidential
Information. 

 2.2. Covenant Not to Solicit Customers. During Executive’s employment and the twenty-four
(24) month period following the end of Executive’s employment, Executive shall not, within the geographic territory identified in Section 2.4, engage in any of the following activities, whether on his own behalf or as an officer,
director, stockholder, partner, associate, owner, employee, consultant or independent contractor, nor shall Executive provide material assistance to any other person or entity to do so: 

 

	 	(a)	solicit any customer of the Company or any customer of any Restricted Affiliate, to obtain services that the customer had obtained from the Company or Affiliate from an entity in competition with the Company or
Restricted Affiliate; 

  

	 	(b)	solicit any person or entity which Executive serviced, contracted with or negotiated with on behalf of the Company or any Restricted Affiliate to obtain services that the person or entity had obtained from the Company
or a Restricted Affiliate from an entity in competition with the Company or Restricted Affiliate; 

  

	 	(c)	solicit any person or entity which any employee of Company or any Restricted Affiliate for whom Executive was responsible, serviced, contracted with or negotiated with on behalf of the Company or any Restricted
Affiliate, to obtain services that the customer had obtained from the Company or Affiliate from an entity in competition with the Company or Restricted Affiliate; 

  
 8 

	 	(d)	solicit any customer of the Company or any Restricted Affiliate, the effective solicitation of which would reasonably be expected to benefited by the knowledge of Confidential Information, to obtain services that the
customer had obtained from the Company or an Restricted Affiliate from an entity in competition with the Company or an Restricted Affiliate; 

  

	 	(e)	solicit any vendor or supplier of the Company or a Restricted Affiliate to cease doing business with the Company or Restricted Affiliate, or to provide services to an entity in competition with the Company or any
Restricted Affiliate the effect of which would be to eliminate or diminish the provision of services to the Company or an Restricted Affiliate; or 

  

	 	(f)	encourage any customer of the Company or any Restricted Affiliate to cancel, terminate or refrain from renewing or continuing any contract or business relationship with the Company or a Restricted Affiliate or to
otherwise diminish that Customer’s relationship with the Company or any Restricted Affiliate. 

 2.3. Covenant Not to
Solicit or Hire Employees. During Executive’s employment and the twenty-four (24) month period following the end of Executive’s employment, Executive shall not, engage in any of the following activities, whether or his own behalf
or as an officer, director, stockholder, partner, associate, owner, employee, consultant or independent contractor, nor shall Executive provide material assistance to any other person or entity to do so: 

 

	 	(a)	offer employment to, solicit for employment or hire any employee of the Company or any Restricted Affiliate or any person who was employed by the Company or any Restricted Affiliate during the one year period prior to
the termination of Executive’s employment with the Company; 

  

	 	(b)	offer employment to, solicit for employment or hire any employee of Company or any Restricted Affiliate with respect to whom Executive had responsibility at the time of the termination of Executive’s employment
with the Company or during the one year period prior to the termination of Executive’s employment with the Company; 

  

	 	(c)	offer employment to, solicit for employment or hire any employee of Company or any Restricted Affiliate who was personally known to Executive; or 

 

	 	(d)	offer employment to, solicit for employment or hire any employee of Company or any Restricted Affiliate with respect to whom Executive had responsibility at the time of the termination of Executive’s employment
with the Company or during the one year period prior to the termination of Executive’s employment with Company. 

 2.4.
Geographic Territory. In recognition of the worldwide presence of the Company, the worldwide extent of Executive’s responsibilities, the breadth of Executive’s knowledge of Confidential Information relevant to the operations of the
Company and its Affiliates worldwide, and the relationships with customers, potential customers and contacts important to the Company Business that Executive will develop and that will be available to him as a consequence of the goodwill of the
Company worldwide, Executive agrees that the restrictions set forth in Sections 2.1 and 2.2 above will apply to the broadest geographic territory possible, including the following geographical regions: (a) the world; (b) the United States;
(c) any country in which Executive worked, had responsibility or provided services on behalf of the Company or a Restricted Affiliate; (d) any country in which any employee of the Company or any Restricted Affiliate who was supervised by
Executive, either directly or through other supervisors, had responsibility, provided services or worked; (e) any State of the United States, or similar political subdivision in a foreign country, in which Executive worked, had responsibility,
or provided services on behalf of the Company or any Restricted Affiliate; (f) any State of the United States, or similar political subdivision of any foreign country in which any employee of the Company or any Restricted Affiliate who was
supervised by Executive had responsibility, provided services or worked; (g) any city, or any county or similar political subdivision in any foreign country, in which Executive had responsibility, worked or provided services on behalf of the
Company or any Restricted Affiliate; (h) any city, or any county or similar political subdivision in any foreign country in which any employee of Company or any Restricted Affiliate who was supervised by Executive had responsibility, worked or
provided services on behalf of Company or any Restricted Affiliate; (i) any State, city, metropolitan area or country (or similar political subdivisions in any foreign country) in which Company or any Restricted Affiliate is located or does
business. 

  
 9 

 2.5. Exclusion. Notwithstanding the foregoing, Executive’s ownership of not more than
one (1) percent of the issued and outstanding stock of a corporation the shares of which are regularly traded on a national securities exchange or in the
over-the-counter markets shall not violate this Section 2. 

2.6. Tolling. The period during which Executive must refrain from the activities set forth in Sections 2.1, 2.2 and 2.3 shall be tolled
during any period in which he fails to abide by those provisions. 
 2.7. Definitions. As used in this Agreement: 

 

	 	(a)	“Affiliate(s)” shall mean: (i) any Company parent, subsidiary or related entity; and/or (ii) any entity directly or indirectly controlled or beneficially owned in whole or part
by Company’s parent, subsidiary or related entity. 

  

	 	(b)	“Company Business” shall mean the business engaged in by the Company, and its Restricted Affiliates, that includes but is not limited to the provision of contract research, sales and marketing
services, market research services, technology services, information services and consulting services to pharmaceutical, biotechnology, medical device and healthcare entities. 

 

	 	(c)	“Restricted Affiliates” shall mean any Affiliate of the Company with which Executive worked, had responsibility or supervisory authority, or which uses Confidential Information of the Company
about which Executive has knowledge. 

 3. Assignment of Inventions. 

3.1. Proprietary Rights; Inventions. The term “Proprietary Rights” shall mean all trade secret, patent,
copyright, mask work, trademark and other intellectual property rights throughout the world. The term “Inventions” shall mean any and all inventions, improvements, know-how, trade secrets,
confidential and proprietary information, trademarks, service marks and other indicia of origin, websites, URLs, domain names, software programs, discoveries, conceptions, preparations and developments, in all stages of development, whether or not
eligible for or covered by patent, copyright or trade secret protection. 
 3.2. Prior Inventions. Inventions, if any, patented or
unpatented, which Executive made prior to the beginning of Executive’s employment with the Company are excluded from the scope of this Agreement. To preclude any possible uncertainty, Executive has provided to Company a complete list of all
Inventions that Executive has, alone or jointly with others, made, authored, conceived, developed, or reduced to practice or caused to be made, authored, conceived, developed, or reduced to practice prior to the beginning of Executive’s
employment with the Company, that Executive considers to be Executive’s property or the property of third parties and that Executive wish to have excluded from the scope of this Agreement (collectively, “Prior
Inventions”). If disclosure of any such Prior Invention would cause Executive to violate any prior confidentiality agreement, Executive understands that Executive is not to list such Prior Inventions in his disclosure to the Company but
is only to disclose a cursory name for each such Invention, a listing of the party to whom it belongs and the fact that full disclosure as to such Inventions has not been made for that reason. If no such disclosure is attached, Executive represents
that there are no Prior Inventions. Notwithstanding anything to the contrary in this Agreement, Executive agrees that Executive will not incorporate, or permit to be incorporated, any Inventions in which Executive or any third parties own any rights
in any Company product, process, service, machine, or other Company Inventions (as defined below) without the Company’s prior written consent. Without limiting any other remedy to which the Company may be entitled, if in the course of
Executive’s employment with the Company, (a) Executive incorporates an Invention that Executive owns or controls into a Company product, process, service, machine, or other Company Invention, Executive agrees to grant and hereby grants to
the Company a nonexclusive, royalty-free, paid-up irrevocable, perpetual, transferable, worldwide license (with rights to sublicense through multiple tiers of sublicensees) under such Inventions and all
Proprietary Rights therein to make, have made, modify, use, sell, have sold, import, export and otherwise exploit any and all products, processes, services, machines or other Company Inventions, and (b) Executive incorporates an

  
 10 

 
Invention that Executive does not own or control into a Company product, process, service, machine, or other Company Invention, Executive shall take all reasonable action necessary to cause the
third party who owns or controls such Invention to grant to the Company the rights described in the foregoing sentence. 
 3.3.
Assignment of Inventions. Executive agrees to assign and hereby assigns all Executive’s right, title and interest in and to any and all Inventions and all Proprietary Rights with respect thereto (except to the extent that such Inventions
constitute works for hire or otherwise belong to the Company by operation of law), which (a) are related to the Company’s Business or actual or demonstrably anticipated research or development or (b) are developed during Company time
or using Company resources, and that in each case are made, authored, conceived, developed, or reduced to practice by Executive, either alone or jointly with others, during the period of Executive’s employment with the Company. Inventions
assigned to the Company, or to a third party as directed by the Company pursuant to this Section 3.3, are hereinafter referred to as “Company Inventions”. Executive further agrees to waive and hereby waives and agrees
never to assert any and all moral rights in any Company Inventions, such as the right to be named as author, the right to modify, the right to prevent mutilation and the right to prevent commercial exploitation, whether arising under the Berne
Convention or otherwise, and all other similar rights regardless of whether such right is denominated or generally referred to as a “moral right.” 

3.4. Obligation to Keep Company Informed. Executive will promptly disclose to the Company fully and in writing all Inventions that are
made, authored, conceived, developed or reduced to practice by Executive, either alone or jointly with others, during the period of Executive’s employment with the Company and for a two (2) year period thereafter. At the time of each such
disclosure, Executive will advise the Company in writing of any Inventions that Executive believes are non-assignable Inventions under the provisions of applicable law (i.e., inventions that Executive
developed entirely on Executive’s own time without using the Company’s equipment, supplies, facility or trade secret information, unless such Invention (a) relates to the Company’s Business or actual or demonstrably anticipated
research or development, or (b) results from any work performed by Executive for the Company) and Executive will at that time provide to the Company in writing all evidence necessary to substantiate that conclusion. 

3.5. Works for Hire. Executive acknowledges and agrees that all original works of authorship which are made by Executive (solely or
jointly with others) within the scope of Executive’s employment and which are protectable by copyright are “works made for hire,” pursuant to the United States Copyright Act (17 U.S.C., Section 101). 

3.6. Enforcement of Proprietary Rights. Executive agrees that Executive will assist the Company in every proper way to obtain, and from
time to time enforce, United States and foreign Proprietary Rights relating to Company Inventions in any and all countries. To that end Executive will execute, verify and deliver such documents and perform such other acts (including appearances as a
witness) as the Company may reasonably request for use in applying for, obtaining, perfecting, evidencing, sustaining and enforcing such Proprietary Rights and the assignment thereof. In addition, Executive agrees that Executive will execute, verify
and deliver assignments of such Proprietary Rights to the Company or its designee. Any such assistance provided during the term of Executive’s employment will be provided without additional compensation. Executive’s obligation to assist
the Company with respect to Proprietary Rights relating to such Company Inventions in any and all countries shall continue beyond the termination of Executive’s employment, but the Company shall compensate Executive at a reasonable rate after
Executive’s termination for the time actually spent by Executive and for any reasonable expenses actually incurred by Executive thereafter at the Company’s request on such assistance. In the event the Company is unable for any reason,
after reasonable effort, to secure Executive’s signature on any document needed in connection with the actions specified in the preceding paragraph, Executive hereby irrevocably designates and appoints the Company and each of its duly
authorized officers and agents as Executive’s agent and attorney in fact, which appointment is coupled with an interest, to act for and on Executive’s behalf to execute, verify and file any such documents and to do all other lawfully
permitted acts to further the purposes of the preceding paragraph with the same legal force and effect as if executed by Executive. Executive hereby waives and quitclaims to the Company any and all claims, of any nature whatsoever, which Executive
now or may hereafter have for infringement of any Proprietary Rights assigned hereunder to the Company. 
 3.7. Irrevocable
Assignment. The Company’s ownership of all Company Inventions that are made, authored, conceived, developed or reduced to practice by Executive, either alone or jointly with others, during the period of

  
 11 

 
Executive’s employment with the Company, as assigned to the Company pursuant to this Agreement or by operation of law, shall not be subject to revocation or rescission in the event of a
dispute between the Company and Executive concerning payment of compensation or benefits to Executive, unless Executive proves that the Company acquired ownership thereof fraudulently. 

4. Non-Disparagement. Executive agrees not to make any disclosures, issue any statements or otherwise cause to
be disclosed any information which is designed, intended or might reasonably be anticipated to disparage the Company, its officers or directors, its business, services, products, technologies and/or personnel. Nothing in this Section is intended,
nor shall be construed, to (a) prohibit Executive from any communications to, or participation in any investigation or proceeding conducted by, any governmental agency with jurisdiction concerning the terms, conditions and privileges of
employment or jurisdiction over the Company’s business, or (b) prevent Executive from otherwise engaging in any legally protected activity. 
 5.
Records. Executive agrees to keep and maintain adequate and current records of all Confidential Information learned or received by Executive and all Inventions made, authored, conceived, developed or reduced to practice by Executive during
the period of Executive’s employment with the Company, which records shall be available to, and to the extent constituting Confidential Information or Company Inventions shall remain the sole property of, the Company at all times. 

6. No Conflicting Obligation. Executive represents that Executive’s performance of all the terms of this Agreement and as an employee of the
Company do not and will not breach any (a) agreement to keep in confidence information acquired by Executive in confidence or in trust prior to Executive’s employment by the Company, or (b) agreement with or obligation to any third
party to which he is otherwise bound, or faculty or staff appointment with a university, government or other research institution). Executive has not entered into, and Executive agrees that Executive will not enter into, any agreement, either
written or oral, in conflict herewith. 
 7. Return of Company Materials. When Executive leaves the employ of the Company, Executive agrees that:
(a) Executive will return all the Company property (including, but not limited to, credit cards; keys; company car; cell phone; air card; access cards; thumb drive(s), laptop(s), personal digital devices and all other computer hardware and
software; records, files, documents, manuals, and other documents in whatever form they exist, whether electronic, hard copy or otherwise and all copies, notes or summaries thereof which Executive created, received or otherwise obtained in
connection with Executive’s employment); (b) Executive will not delete any emails, files or other information from any Company computer or device prior to Executive’s return of the property except in strict accordance with Company
policy; and (c) Executive will permanently delete any Company information that may reside on Executive’s personal computer(s), other devices or accounts and submit all personal computers, phones and other devices which Executive used for
Company business, and will identify all personal accounts on which Company information has been placed and related passwords, to a third party vendor, as may be designated by the Company, for inspection and removal of any Company-related
information. Executive further agrees that any property situated on the Company’s premises and owned by the Company, including disks and other storage media, filing cabinets or other work areas, is subject to inspection by Company personnel at
any time with or without notice. 
 8. Publicity. Executive hereby irrevocably consents to any and all uses and displays, by the Company and its
agents, representatives and licensees, of Executive’s name, voice, likeness, image, appearance and biographical information in, on or in connection with any pictures, photographs, audio and video recordings, digital images, websites, television
programs and advertising, other advertising and publicity, sales and marketing brochures, books, magazines, other publications, CDs, DVDs, tapes and all other printed and electronic forms and media throughout the world, at any time during or after
the period of his employment by the Company, for all legitimate commercial and business purposes of the Company without further consent from or royalty, payment or other compensation to Executive. 

9. Legal and Equitable Remedies for Breach of Certain Provisions. Executive acknowledges that his failure to abide by Sections 1 (Nondisclosure), 2
(Competitive Business Activities), or 3 (Inventions) of this Agreement would cause irreparable harm to the Company and/or its Affiliates for which legal remedies would be inadequate. Therefore, in addition to any legal or other relief to which the
Company and/or its Affiliates may be entitled by virtue of Executive’s failure to abide by these provisions: (a) the Company and its Affiliates may seek legal and equitable 

  
 12 

 
relief, including but not limited to preliminary and permanent injunctive relief, for Executive’s actual or threatened failure to abide by these provisions; (b) Executive will return
all post-termination payments received, including but not limited to those received pursuant to any employment contract or agreement or severance plan in which Executive participates; and (c) if, as a result of Executive’s failure to abide
by the Competitive Business Activities provisions, any commission or fee becomes payable to Executive or to any person, corporation or other entity with which Executive has become employed or otherwise associated, Executive shall pay the Company or
cause the person, corporation or other entity with whom he has become employed or otherwise associated to pay the Company an amount equal to such commission or fee. In the event that the Company or its Affiliates exercises its right to require
Executive to return all post-termination payments received pursuant to any employment contract or agreement or severance plan in which Executive participates hereof, Executive shall remain obligated to abide by the terms of this Agreement, including
but not limited to Sections 1 (Nondisclosure), 2 (Competitive Business Activities), and 3 (Inventions) set forth in this Agreement. 
 10. Notification
of New Employer. In the event that Executive leaves the employ or retention of the Company, Executive hereby consents to the notification of Executive’s new employer of Executive’s rights and obligations under this Agreement. 

11. Governing Law; Consent to Personal Jurisdiction and Forum. This Agreement shall be construed, interpreted, and governed in accordance with and by
North Carolina law, without regard to the conflicts of laws principles thereof. The parties agree that the state and federal courts in North Carolina shall have jurisdiction (non-exclusive) for the
adjudication of all disputes arising out of this Agreement, and Executive consents to the exercise of personal jurisdiction over Executive in any such adjudication and hereby waives any and all objections and defenses to the exercise of such
personal jurisdiction and such venue. 
 12. Severability. Executive agrees that the restrictions contained in this Agreement are reasonable and
necessary, are valid and enforceable, and do not impose a greater restraint than necessary to protect the Company’s legitimate business interests. If any one or more of the provisions contained in this Agreement shall for any reason be held by
a court to be excessively broad as to duration, geographical scope, activity or subject, the parties intend that such court would reduce, or “blue pencil” such provision by limiting and reducing it, so as to be enforceable to the extent
compatible with the applicable law as it shall then appear. In case any one or more of the provisions contained in this Agreement shall, for any reason (including the failure of a court to “blue pencil” a provision pursuant to the
foregoing sentence), be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be construed as if such invalid,
illegal or unenforceable provision had never been contained herein; provided, however, that if the absence of such provision causes a material adverse change in either the risks or benefits of this Agreement to either the Company or Executive, the
Company and Executive shall negotiate in good faith a commercially reasonable substitute or replacement for the invalid or unenforceable provision. 
 13.
Successors and Assigns. This Agreement will be binding upon Executive’s heirs, executors, administrators and other legal representatives and will be for the benefit of the Company, its Affiliates, its successors, and its assigns. 

14. Waiver. No waiver by the Company of any breach of this Agreement shall be a waiver of any preceding or succeeding breach. No waiver by the Company
of any right under this Agreement shall be construed as a waiver of any other right. The Company shall not be required to give notice to enforce strict adherence to all terms of this Agreement. 

15. Entire Agreement. This Agreement and the Letter Agreement contain the entire agreement of Executive and the Company and its Affiliates with respect
to the matters set forth herein and supersede all previous negotiations and discussions, agreements and understandings regarding such matters. In the event of any conflict between this Agreement and any other agreement with the Company or its
Affiliates, the terms of the agreement which are most restrictive shall control. It is understood that this Agreement does not constitute an express or implied employment contract for any definite period of time and that Executive’s employment
with the Company is “at will” meaning that either the Company or Executive can end the employment relationship at any time, with or without cause. 

  
 13 

 16. Counterparts. This Agreement may be executed in separate counterparts, each of which shall be deemed
an original, but all of which taken together shall constitute one and the same instrument. 
 IN WITNESS WHEREOF, the parties hereto have executed this
Agreement as of the date written below. 
  

					
	QUINTILES IMS INCORPORATED
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	
	
	W. RICHARD STAUB III 
		
		 	  

		 	Name:	 	
		
		 	  

		 	Date	 	

  
 14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}]]